Pharmacy diabetes screening looked like a flop. So why is it before MSAC?
Analysis: The trial was heavily criticised and cost more than $8,000 for every case of type 2 diabetes detected.
As far as experiments go, the Pharmacy Guild of Australia’s trial of pharmacy-based screening for type 2 diabetes did not appear to be a success.
Funded by the Federal Government, it ran across 340 pharmacies, but picked up just 136 cases out of the 14,100 patients screened.
